Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 237-242

  Dupuis, Michel ^a   Leclercq, Roland ^a,b  

^a CHU CÔTE DE NACRE   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; MIKAMYCIN B; QUINUPRISTIN; RPR 132552; RPR 202868; STREPTOGRAMIN; UNCLASSIFIED DRUG; XRP 2868;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG POTENCY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ERM GENE; GENE EXPRESSION; GENOTYPE; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MICROBIAL; GRAM-POSITIVE COCCI; MICROBIAL SENSITIVITY TESTS; STREPTOGRAMIN A; STREPTOGRAMIN B; STREPTOGRAMINS;

EID: 29944433043     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.237-242.2006     Document Type: Article

References (23)

1. Angot, P., M. Vergnaud, M. Auzou, R. Leclercq, et al. 2000. Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 19:755-758.
2. Arthur, M., F. Depardieu, H. A. Snaith, and P. Courvalin. 1994. Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors. Antimicrob. Agents Chemother. 38:1899-1903.
3. Barriere, J. C., N. Berthaud, D. Beyer, S. Dutka-Malen, J. M. Paris, and J. F. Desnottes. 1998. Recent developments in streptogramin research. Curr. Pharm. Des. 4:155-180.
4. Bozdogan, B., and R. Leclercq. 1999. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob. Agents Chemother. 43:2720-2725.
5. Canu, A., and R. Leclercq. 2001. Overcoming bacterial resistance by dual target inhibition: the case of streptogramins. Curr. Drug Targets Infect. Disord. 1:215-225.
6. Canu, A., B. Malbruny, M. Coquemont, T. A. Davies, P. C. Appelbaum, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:125-131.
7. B phenotype of resistance according to the erm gene type. Int. J. Antimicrob. Agents 24:444-449.
8. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2004. Communiqué 2004. Société Française de Microbiologie. http://www.sfm.asso .fr/. Last release, January 2004.
9. Dina, J., B. Malbruny, and R. Leclercq. 2003. Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A. Antimicrob. Agents Chemother. 47:2307-2309.
10. Eliopoulos, G. M., M. J. Ferraro, C. B. Wennersten, and R. C. Moellering, Jr. 2005. In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria. Antimicrob. Agents Chemother. 49:3034-3039.
11. Fuchs, P. C., A. L. Barry, and S. D. Brown. 2000. Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator. Antimicrob. Agents Chemother. 44:2880-2882.
12. Goldstein, E. J. C., D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, H. T. Fernandez, and A. Bryskier. 2005. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomyces, and lactobacilli. Antimicrob. Agents Chemother. 49:408-413.
13. Hershberger, E., S. Donabedian, K. Konstantinou, M. J. Zervos. 2004. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin. Infect. Dis. 38:92-98.
14. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
15. Malbruny, B., A. Canu, B. Bozdogan, V. Zarrouk, B. Fantin, and R. Leclercq. 2002. Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2200-2207.
16. Malbruny, B., A. M. Werno, T. P. Anderson, D. R. Murdoch, and R. Leclercq. 2004. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. J. Antimicrob. Chemother. 54:1040-1044.
17. National Committee for Clinical Laboratory Standards. 1992. Methods for determining bactericidal activity of antimicrobial agents. Proposed guideline M26-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Pankuch, G. A., L. M. Kelly, G. Lin, A. Bryskier, C. Couturier, M. R. Jacobs, and P. C. Appelbaum. 2003. Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and Haemophilus species. Antimicrob. Agents Chemother. 47:3270-3274.
19. Petsaris, O., F. Miszczak, M. Gicquel-Bruneau, A. Perrin-Guyomard, F. Humbert, P. Sanders, and R. Leclercq. 2005. Combined antimicrobial resistance in Enterococcus faecium isolated from chickens. Appl. Environ. Microbiol. 71:2796-2799.
20. Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214.
21. Rubinstein, E., P. Prokocimer, and G. H. Talbot. 1999. Safety and tolerability of quinupristin-dalfopristin: administration guidelines. J. Antimicrob. Chemother. 44(Suppl. A):37-46.
22. Singh, K. V., G. M. Weinstock, and B. E. Murray. 2002. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob. Agents Chemother. 46:1845-1850.
23. Zarrouk, V., B. Bozdogan, R. Leclercq, L. Garry, C. Carbon, and B. Fantin. 2000. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 44:1168-1173.